Abstract:Spherical crystallization, a particle engineering technique, has been commonly used to modify the size and shape of particles to enhance the micromeritics properties of a powder and facilitate tablet formulation development. By identifying the key factors affecting the generation of spherical agglomerates and the underlying mechanism, spherical agglomerates with optimal size, shape and density can be obtained, presenting excellent flowability, tabletability and dissolution. The goals of this thesis work include: (i) prepare and evaluate the properties of the spherical agglomerates of drugs using the two main methods including spherical agglomeration (SA) and quasi-emulsion solvent diffusion (QESD) , (ii) explore high drug loading direct compression tablet formulations enabled by the spherical crystallization technique, (iii) develop a spherical cocrystallization technique to simultaneously improve the manufacturability and dissolution of drugs, and (iv) reduce the punch sticking propensity via a polymer assisted QESD method. To successfully prepare the spherical agglomerates, it is crucial to select a solvent system-based phase diagram. Spherical agglomerates of a model API, ferulic acid (FA), via a QESD process presented exceptional flowability and tabletability. Such spherical FA crystals enabled the development of a direct compression tablet formulation containing 99% of the API. Spherical griseofulvin agglomerates prepared by a SA process, exhibited not only good flowability but also excellent tabletability. The unexpected profoundly improved tabletability was attributed to a micro porous structure of primary crystals, due to an in-situ solvation and desolvation during the SA process, which enhanced the plasticity of the agglomerates. For low water-soluble drugs, spherical crystallization of more soluble cocrystals, i.e., spherical cocrystallization, is an enabling technology to simultaneously improve the manufacturability and dissolution and enable the development of high drug loading tablet formulation. Moreover, spherical agglomerates of celecoxib obtained via a polymer assisted QESD process not only showed substantially improved tabletability and flowability but also significantly reduced punch-sticking propensity. A thin layer of polymer coating onto the agglomerates surface, confirmed by SEM and XPS analysis, explains the reduced punch sticking propensity due to the physical barrier of polymer between the drug and punch.

Dissolution Performance Enhancement of Poorly Water-Soluble API by Crystallization from Phase-Separated Melt

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's

Improve the Manufacturability and Dissolution Performance of Drugs Through Spherical Crystallization

Drug Solubilization by Means of a Surface-Modified Edible Biopolymer Enabled by Hot Melt Extrusion

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates

Enhancement Dissolution of Poorly Water Soluble Drug by Micronization

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition

Mechanisms of drug release from a melt-milled, poorly soluble drug substance

Insights into the Mechanism of Enhanced Dissolution in Solid Crystalline Formulations

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers

Dissolution Of Crystalline Pharmaceuticals: Experimental Investigation And Thermodynamic Modeling

Modeling and predicting the influence of variable factors on dissolution of crystalline pharmaceuticals

Compact Crystallization, Filtration, and Drying for the Production of Active Pharmaceutical Ingredients

Review of melt crystallization in the pharmaceutical field, towards crystal engineering and continuous process development

Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization

Amorphous Solid Dispersions: Implication of Method of Preparation and Physicochemical Properties of API and Excipients

Highly Efficient Production of Desired Solid Forms of Drugs with Improved Mechanical Properties Via an Organic Solvent-Free Sublimation Process

Crystal Engineering in the design of New Solid Pharmaceutical Forms with enhanced pharmaceutical properties